BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 12872688)

  • 1. Perspectives. Medicare Rx: even when it's over, it won't be over.
    Med Health; 2003 Jun; 57(25):7-8. PubMed ID: 12872688
    [No Abstract]   [Full Text] [Related]  

  • 2. Perspectives. Medicare overhaul: it's not just about drugs.
    Med Health; 2003 Jul; 57(26):7-8. PubMed ID: 12898810
    [No Abstract]   [Full Text] [Related]  

  • 3. Translating dreams into reality. It's up to regulators, private sector to carry out best intentions of Congress.
    Tieman J
    Mod Healthc; 2003 Dec 22-29; 33(51):20-1, 26-7. PubMed ID: 14723079
    [No Abstract]   [Full Text] [Related]  

  • 4. We're back, says Tauzin.
    Med Health; 2001 Mar; 55(13):6-7. PubMed ID: 11301789
    [No Abstract]   [Full Text] [Related]  

  • 5. The new Medicare law. Doctors cheer.
    Guglielmo WJ
    Med Econ; 2004 Jan; 81(1):37, 40, 47. PubMed ID: 14959604
    [No Abstract]   [Full Text] [Related]  

  • 6. The game that won't end. Months after passage, drug benefit law remains a political football.
    Sloane T
    Mod Healthc; 2004 Mar; 34(10):30. PubMed ID: 15069932
    [No Abstract]   [Full Text] [Related]  

  • 7. 'Real change' in system won't come overnight. Interview by Patrick Mullen.
    Scully T
    Manag Care; 2002 May; 11(5):36, 39-42. PubMed ID: 12061158
    [No Abstract]   [Full Text] [Related]  

  • 8. Medicare reform opinions. Flawed program needs fixing.
    Vaughan B
    Mod Healthc; 2003 Dec 22-29; 33(51):23. PubMed ID: 14723083
    [No Abstract]   [Full Text] [Related]  

  • 9. Washington forecast: much talk. Any action?
    Pretzer M
    Med Econ; 2001 May; 78(10):38-40, 43-4. PubMed ID: 11409267
    [No Abstract]   [Full Text] [Related]  

  • 10. CMS rules on employers, formularies, PPOs raise concerns.
    Med Health; 2004 Sep; 58(34):2-3. PubMed ID: 15487559
    [No Abstract]   [Full Text] [Related]  

  • 11. Perspectives. Gore: more funds for Medicare, incremental steps for access.
    Clemmitt M
    Med Health; 2000 Jul; 54(27):suppl 1-4. PubMed ID: 11066633
    [No Abstract]   [Full Text] [Related]  

  • 12. Perspectives. Now what? Wonks weigh in on Rx bill's future.
    Med Health; 2003 Dec; 57(44):1, 7-8. PubMed ID: 14696247
    [No Abstract]   [Full Text] [Related]  

  • 13. Dramatic improvement or death spiral--two members of congress assess the Medicare bill.
    Kennedy EM; Thomas B
    N Engl J Med; 2004 Feb; 350(8):747-51. PubMed ID: 14973220
    [No Abstract]   [Full Text] [Related]  

  • 14. Defining a future for fee-for-service Medicare.
    Foote SB; Halaas GW
    Health Aff (Millwood); 2006; 25(3):864-8. PubMed ID: 16684754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marketing Medicare. Legislation would force federal program to compete with private sector.
    Benko LB
    Mod Healthc; 2003 Dec 22-29; 33(51):30-3. PubMed ID: 14723087
    [No Abstract]   [Full Text] [Related]  

  • 16. Medicaid, Medicare reform proposals stir debate over prescription benefits.
    Garry B
    Formulary; 1995 Sep; 30(9):546, 545. PubMed ID: 10151738
    [No Abstract]   [Full Text] [Related]  

  • 17. Perspectives. E-prescribing, formularies play big roles in Rx bill. 2.
    Med Health; 2003 Dec; 57(45):1, 7-8. PubMed ID: 14723167
    [No Abstract]   [Full Text] [Related]  

  • 18. An emerging Medicare reform package.
    Ferman JH
    Healthc Exec; 2002; 17(4):58-9. PubMed ID: 12098894
    [No Abstract]   [Full Text] [Related]  

  • 19. Seniors finally get help. Drug support limited by 'doughnut hole,' costs.
    Mantone J; Tieman J
    Mod Healthc; 2003 Dec 22-29; 33(51):30-1. PubMed ID: 14723088
    [No Abstract]   [Full Text] [Related]  

  • 20. Private, individual drug coverage in the current Medicare market.
    Boccuti C; Moon M
    Policy Brief Commonw Fund; 2003 Oct; (679):1-10. PubMed ID: 14562796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.